Literature DB >> 23478298

RNA-guided genome editing à la carte.

Philippe Horvath1, Rodolphe Barrangou.   

Abstract

Two recent papers in Science illustrate how the prokaryotic CRISPR-Cas immune system machinery, which typically targets invasive genetic elements such as viruses and plasmids, can be converted into a sophisticated molecular tool for next-generation human genome editing. The versatile Cas9 RNA-guided endonuclease can be readily reprogrammed using customizable small RNAs for sequence-specific single- or double-stranded DNA cleavage.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23478298      PMCID： PMC3674385          DOI： 10.1038/cr.2013.39

Source DB:  PubMed          Journal:  Cell Res        ISSN： 1001-0602            Impact factor:   25.617


  10 in total

1.  The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA.

Authors:  Josiane E Garneau; Marie-Ève Dupuis; Manuela Villion; Dennis A Romero; Rodolphe Barrangou; Patrick Boyaval; Christophe Fremaux; Philippe Horvath; Alfonso H Magadán; Sylvain Moineau
Journal:  Nature       Date:  2010-11-04       Impact factor: 49.962

2.  CRISPR provides acquired resistance against viruses in prokaryotes.

Authors:  Rodolphe Barrangou; Christophe Fremaux; Hélène Deveau; Melissa Richards; Patrick Boyaval; Sylvain Moineau; Dennis A Romero; Philippe Horvath
Journal:  Science       Date:  2007-03-23       Impact factor: 47.728

Review 3.  CRISPR/Cas, the immune system of bacteria and archaea.

Authors:  Philippe Horvath; Rodolphe Barrangou
Journal:  Science       Date:  2010-01-08       Impact factor: 47.728

4.  Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria.

Authors:  Giedrius Gasiunas; Rodolphe Barrangou; Philippe Horvath; Virginijus Siksnys
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-04       Impact factor: 11.205

Review 5.  Advances in targeted genome editing.

Authors:  Pablo Perez-Pinera; David G Ousterout; Charles A Gersbach
Journal:  Curr Opin Chem Biol       Date:  2012-07-20       Impact factor: 8.822

Review 6.  Evolution and classification of the CRISPR-Cas systems.

Authors:  Kira S Makarova; Daniel H Haft; Rodolphe Barrangou; Stan J J Brouns; Emmanuelle Charpentier; Philippe Horvath; Sylvain Moineau; Francisco J M Mojica; Yuri I Wolf; Alexander F Yakunin; John van der Oost; Eugene V Koonin
Journal:  Nat Rev Microbiol       Date:  2011-05-09       Impact factor: 60.633

7.  A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity.

Authors:  Martin Jinek; Krzysztof Chylinski; Ines Fonfara; Michael Hauer; Jennifer A Doudna; Emmanuelle Charpentier
Journal:  Science       Date:  2012-06-28       Impact factor: 47.728

8.  Multiplex genome engineering using CRISPR/Cas systems.

Authors:  Le Cong; F Ann Ran; David Cox; Shuailiang Lin; Robert Barretto; Naomi Habib; Patrick D Hsu; Xuebing Wu; Wenyan Jiang; Luciano A Marraffini; Feng Zhang
Journal:  Science       Date:  2013-01-03       Impact factor: 47.728

9.  RNA-guided human genome engineering via Cas9.

Authors:  Prashant Mali; Luhan Yang; Kevin M Esvelt; John Aach; Marc Guell; James E DiCarlo; Julie E Norville; George M Church
Journal:  Science       Date:  2013-01-03       Impact factor: 47.728

10.  CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III.

Authors:  Elitza Deltcheva; Krzysztof Chylinski; Cynthia M Sharma; Karine Gonzales; Yanjie Chao; Zaid A Pirzada; Maria R Eckert; Jörg Vogel; Emmanuelle Charpentier
Journal:  Nature       Date:  2011-03-31       Impact factor: 49.962
  10 in total
  10 in total

1.  CRISPRs extending their reach: prokaryotic RNAi protein Cas9 recruited for gene regulation.

Authors:  Nadja Heidrich; Jörg Vogel
Journal:  EMBO J       Date:  2013-06-11       Impact factor: 11.598

Review 2.  Breaking bad: R-loops and genome integrity.

Authors:  Julie Sollier; Karlene A Cimprich
Journal:  Trends Cell Biol       Date:  2015-06-01       Impact factor: 20.808

Review 3.  The role of CRISPR-Cas systems in virulence of pathogenic bacteria.

Authors:  Rogier Louwen; Raymond H J Staals; Hubert P Endtz; Peter van Baarlen; John van der Oost
Journal:  Microbiol Mol Biol Rev       Date:  2014-03       Impact factor: 11.056

4.  Rad51, friend or foe?

Authors:  Sue Mei Tan-Wong; Nick J Proudfoot
Journal:  Elife       Date:  2013-06-11       Impact factor: 8.140

5.  Targeted mutagenesis in rice using CRISPR-Cas system.

Authors:  Jin Miao; Dongshu Guo; Jinzhe Zhang; Qingpei Huang; Genji Qin; Xin Zhang; Jianmin Wan; Hongya Gu; Li-Jia Qu
Journal:  Cell Res       Date:  2013-09-03       Impact factor: 25.617

Review 6.  Exploiting CRISPR/Cas: interference mechanisms and applications.

Authors:  Hagen Richter; Lennart Randau; André Plagens
Journal:  Int J Mol Sci       Date:  2013-07-12       Impact factor: 5.923

7.  Slow and steady wins the race: Spatial and stochastic processes and the failure of suppression gene drives.

Authors:  Jeff F Paril; Ben L Phillips
Journal:  Mol Ecol       Date:  2022-07-22       Impact factor: 6.622

8.  Special focus CRISPR-Cas.

Authors:  Anita Marchfelder
Journal:  RNA Biol       Date:  2013-05       Impact factor: 4.652

9.  Phylogeny of Cas9 determines functional exchangeability of dual-RNA and Cas9 among orthologous type II CRISPR-Cas systems.

Authors:  Ines Fonfara; Anaïs Le Rhun; Krzysztof Chylinski; Kira S Makarova; Anne-Laure Lécrivain; Janek Bzdrenga; Eugene V Koonin; Emmanuelle Charpentier
Journal:  Nucleic Acids Res       Date:  2013-11-22       Impact factor: 16.971

10.  (Non-)translational medicine: targeting bacterial RNA.

Authors:  Adam M Dinan; Brendan J Loftus
Journal:  Front Genet       Date:  2013-11-08       Impact factor: 4.599
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.